Investment Objective


Actively managed and diversified portfolio of typically 20 – 40 high quality emerging market companies diversified by geography, industry and market capitalisation.

A long-term investment approach based on the belief that superior investment returns rely on fundamental investment research, good judgement and experience.

The ability for the portfolio manager to call on the research from typically 400 research meetings a year visiting companies in their home market.

Fund Facts

Benchmark MSCI Emerging Markets Total Return Index in AUD
Stock Range 20 – 40
Individual Stock Weight 0-10%
Inception Date 22 July 2020
Fund Size $7.2m
Distribution Frequency Semi-Annual
Management Fees 1.44% p.a.
Performance Fee 20.5% of after-management fee performance over the Benchmark subject to a relative high-water mark
Buy/Sell Spread 0.50% / 0.50%
Currency Unhedged
APIR Code WRA4779AU
ARSN 642 392 863

Performance, Prices & Distributions


Net returns as at 31 October 2020

1 month
%

3 months
%

FYTD
%

1 year
%

3 years
% pa

5 years
% pa

10 years
% pa

Since inception (22/07/2020)
% pa

Fund +3.38 +3.89 +5.84 - - - - +5.84
Benchmark +4.17 +4.82 +4.58 - - - - +4.58
Relative Return -0.79 -0.93 +1.26 - - - - +1.26

Past performance is not a reliable indicator of future performance. The return of capital is not guaranteed.
This is a new fund. Fund inception date 22 July 2020.

Current Unit Price
Prices as at 25 November 2020

Month-end Unit Price
Prices as at 30 October 2020

Application $1.0957 $1.0637
Redemption $1.0848 $1.0531

This is a new fund. Fund inception date 22 July 2020.

Distribution

Distribution

Reinvestment Price

30 June 2020 N/A N/A

This is a new fund. Fund inception date 22 July 2020.

Portfolio Holdings

As at 31 October 2020

Company Name Sector Country Weighting
iShares MSCI India ETF* ETF India 12.6%
Top Glove Corp Health Care Malaysia 8.4%
Techtronic Industries Co., Ltd. Industrials Hong Kong 8.3%
Taiwan Semiconductor Manufacturing Co., Ltd. Information Technology Taiwan 7.7%
Samsung Electronics Co., Ltd. Information Technology South Korea 6.6%
Hartalega Holdings Bhd. Health Care Malaysia 6.1%
LG Household & Health Care Ltd Consumer Staples South Korea 4.9%
Sk Hynix Information Technology South Korea 3.7%
Mercadolibre Consumer Discretionary United States 3.5%
Hdfc Bank Financials India 3.4%
65.2%

Portfolio holdings are subject to change. *This is a new fund with an inception date 22 July 2020. Alternative exposure for the Fund until trading account in India is activated.

As at 31 October 2020

 
23% Information Technology
16% Industrials
15% Healthcare
12% India ETF
10% Consumer Staples
7% Financials
6% Communication Services
3% Consumer Discretionary
2% Materials
6% Cash
 

As at 31 October 2020

 
16% India
16% Malaysia
15% Other
15% South Korea
13% Taiwan
11% China/HK
6% Mexico
1% Thailand
1% Brazil
 

Fund Ratings

Organisation Rating / Recommendation
Zenith Investment Partners Recommended